Table 2.
Signs and symptoms of prolapse among 368 vaginally nulliparous women, and comparison of CS only vs nulliparae
| Population N = 368 | CS only n = 184 | No births n = 184 | P‐value, OR (CI) | Adjusted P‐value, OR (CI) | |
|---|---|---|---|---|---|
| Symptoms of prolapse (%) (n = 368) | 81 (22%) | 47 (26%) | 34 (18%) | 0.1 | 0.2 |
| 1.5 (0.9‐2.5) | 1.51 (0.8‐2.89) | ||||
| Significant prolapse on POP‐Q (n = 362) | 106 (29%) | 59/180 (33%) | 47/182 (26%) | 0.13 | 0.5 |
| 1.4 (0.9‐2.21) | 1.25 (0.70‐2.21) | ||||
| Anterior compartment stage ≥2 (n = 363) | 63 (17%) | 38/181 (21%) | 25/182 (14%) | 0.07 | 0.08 |
| 1.67 (0.96‐2.90) | 1.81 (0.93‐3.55) | ||||
| Uterine prolapse stage ≥1 (n = 293) | 26 (9%) | 11/139 (8%) | 15/154 (10%) | 0.7 | 0.6 |
| 0.8 (0.35‐1.8) | 0.77 (0.25‐2.35) | ||||
| Posterior compartment stage ≥2 (n = 363) | 70 (19%) | 43/181 (24%) | 27/182 (15%) | 0.03 | 0.5 |
| 1.79 (1.05‐3.05) | 1.27 (0.64‐2.57) | ||||
| Significant prolapse on US (n = 367) | 71 (19%) | 39/183 (21%) | 32/184 (17%) | 0.35 | 1 |
| 1.29 (0.77‐2.16) | 0.99 (0.51‐1.92) | ||||
| Significant cystocele on US (n = 367) | 14 (4%) | 9/183 (5%) | 5/184 (3%) | 0.29 | 0.7 |
| 1.85(0.61‐5.64) | 1.27 (0.38‐4.29) | ||||
| Significant central compartment prolapse on US (n = 367) | 23 (6%) | 11/183 (6%) | 12/184 (7%) | 0.84 | 0.94 |
| 0.92 (0.39‐2.13) | 0.96 (0.33‐2.78) | ||||
| Significant rectal descent on US (n = 367) | 46 (13%) | 27/183 (15%) | 19/184 (10%) | 0.2 | 0.7 |
| 1.50 (0.80‐2.81) | 1.17 (0.52‐2.65) | ||||
| True rectocele (n = 367) | 68 (19%) | 41/183 (22%) | 27/184 (15%) | 0.06 | 0.07 |
| 1.68 (0.98‐2.87) | 1.94 (0.96‐3.92) |
Univariate and multivariate logistic regression controlling for age, body mass index, chronic constipation and obstructed defecation.
CI, confidence interval; CS, caesarean section; OR, odds ratio; POP‐Q, Pelvic Organ Prolapse Quantification; US, ultrasound